These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8428728)

  • 1. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.
    Fenyves D; Gariépy L; Villeneuve JP
    Hepatology; 1993 Feb; 17(2):301-6. PubMed ID: 8428728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
    Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat.
    Wood AJ; Villeneuve JP; Branch RA; Rogers LW; Shand DG
    Gastroenterology; 1979 Jun; 76(6):1358-62. PubMed ID: 437433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity.
    Ng CY; Ghabrial H; Morgan DJ; Ching MS; Smallwood RA; Angus PW
    Drug Metab Dispos; 2000 Oct; 28(10):1217-21. PubMed ID: 10997943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis.
    Callaghan R; Desmond PV; Paull P; Mashford ML
    Hepatology; 1993 Jul; 18(1):54-60. PubMed ID: 8325621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced extraction of I-propranolol by perfused rat liver in the presence of uremic blood.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1985 May; 233(2):277-84. PubMed ID: 3999018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance by the liver in cirrhosis. II. Characterization of propranolol uptake with the multiple-indicator dilution technique.
    Gariépy L; Fenyves D; Kassissia I; Villeneuve JP
    Hepatology; 1993 Oct; 18(4):823-31. PubMed ID: 8406355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced hepatic clearance of propranolol induced by chronic carbon tetrachloride treatment in rats.
    Iwamoto K; Watanabe J; Araki K; Satoh M; Deguchi N
    J Pharmacol Exp Ther; 1985 Aug; 234(2):470-5. PubMed ID: 4020680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon tetrachloride-induced cirrhosis in rats: influence of the acute effects of the toxin on glucose metabolism.
    Mion F; Géloën A; Agosto E; Minaire Y
    Hepatology; 1996 Mar; 23(3):582-8. PubMed ID: 8617440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance by the liver in cirrhosis. III. Propranolol uptake by the isolated perfused human liver.
    Villeneuve JP; Dagenais M; Huet PM; Lapointe R; Roy A; Marleau D
    Can J Physiol Pharmacol; 1996 Dec; 74(12):1327-32. PubMed ID: 9047043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in hepatic endothelin-1 clearance in cirrhosis.
    Tran Duc AT; Schwab AJ; Simard A; Villeneuve L; Dupuis J
    Clin Sci (Lond); 2003 Aug; 105(2):227-34. PubMed ID: 12708965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.
    Rane A; Wilkinson GR; Shand DG
    J Pharmacol Exp Ther; 1977 Feb; 200(2):420-4. PubMed ID: 839445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of in vivo hepatic extraction ratio from in vitro metabolism by rat hepatocytes.
    Singh K; Tripp SL; Dunton AW; Douglas FL; Rakhit A
    Drug Metab Dispos; 1991; 19(5):990-6. PubMed ID: 1686248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased sensitivity of propranolol clearance to reduced oxygen delivery in the isolated perfused cirrhotic rat liver.
    Hickey PL; McLean AJ; Angus PW; Choo EF; Morgan DJ
    Gastroenterology; 1996 Oct; 111(4):1039-48. PubMed ID: 8831600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of the pharmacokinetics and metabolism of propranolol and antipyrine elicited by indwelling catheters in the rat.
    Chindavijak B; Belpaire FM; De Smet F; Bogaert MG
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1075-9. PubMed ID: 3418510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic pharmacokinetics of propranolol in rats with adjuvant-induced systemic inflammation.
    Hung DY; Siebert GA; Chang P; Whitehouse MW; Fletcher L; Crawford DH; Roberts MS
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G343-51. PubMed ID: 16166348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition kinetics of propranolol isomers in the perfused rat liver.
    Hung DY; Siebert GA; Chang P; Anissimov YG; Roberts MS
    J Pharmacol Exp Ther; 2004 Nov; 311(2):822-9. PubMed ID: 15192084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs.
    Siebert GA; Hung DY; Chang P; Roberts MS
    J Pharmacol Exp Ther; 2004 Jan; 308(1):228-35. PubMed ID: 14566005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship of propranolol pharmacokinetic parameters with portosystemic shunt in CCl4-induced cirrhotic rats].
    Koh DH; Park GT; Kim JM; Yun YS; Lee SH; Kim DU; Kim JB; Choi YY; Kang JS; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):277-87. PubMed ID: 12499785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inflammation and proadifen on the disposition of antipyrine, lignocaine and propranolol in rat isolated perfused liver.
    Chindavijak B; Belpaire FM; Bogaert MG
    J Pharm Pharmacol; 1987 Dec; 39(12):997-1002. PubMed ID: 2894448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.